May 20, 2020
Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus
Dec 31, 2019
Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028
Nov 04, 2019
Respiratory Syncytial Virus: Epidemiology Forecast in Asia-Pacific Markets to 2028
Oct 09, 2019
New Research Examines Key Players Involved in Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Targeted Therapeutics Markets and Key Projects
Sep 20, 2019
Global Parainfluenza Virus Infection Market Insights, Epidemiology and Market Forecast 2019-2028
Sep 10, 2019
Pneumagen Ltd Demonstrates Preclinical Proof-of-Concept for Neumifil(TM) in Respiratory Syncytial Virus Infections
Sep 03, 2019
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults
Jul 29, 2019
Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting
May 28, 2019
Ansun Biopharma Announces First Patient Enrolled In Phase 3 Clinical Trial Evaluating DAS181 In Hospitalized, Immunocompromised Patients With Lower Respiratory Tract Parainfluenza Virus Infection
Nov 27, 2018
Mesa Biotech Receives FDA 510(k) Clearance and CLIA Waiver for Its Accula(TM) RSV Molecular Point of Care Test
Nov 13, 2018
Mesa Biotech Obtains CE Mark for its Accula RSV Molecular Point of Care Test
May 14, 2018
Ansun BioPharma secures $85 million in Series A Financing
Mar 13, 2018
Meissa Vaccines Appoints Dr. Lawrence Blatt as Chairman of the Board of Directors
Feb 28, 2018
RSV Diagnostics Market - Global Forecast to 2022
Feb 16, 2018
RSV Diagnostics Market Worth 929.2 Million USD by 2022
Oct 26, 2017
Paraflu Assay Now FDA Cleared on Hologic's New Panther Fusion® System